Study guide

11.2 Split-Thickness and Full-Thickness Autografting: Mesh Expansion Ratios vs. Sheet Grafts

Certified Burn Registered Nurse CBRN

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Foundations of Burn Care

1.1 CBRN Exam Format, Eligibility, and BCEN Testing Standards 1.2 Anatomy, Histology, and Barrier Functions of the Skin 1.3 Burn Depth Classification and Jackson's Thermal Wound Zones

2 Chapter 2: Pathophysiology of Burn Injury & Systemic Response

2.1 Cellular Pathophysiology and Capillary Permeability in Burn Shock 2.2 Systemic Inflammatory Response Syndrome (SIRS) and MODS 2.3 Pathophysiology of Supraglottic, Subglottic, and Inhalational Injury 2.4 Cellular Phases of Burn Wound Healing and Scar Pathobiology

3 Chapter 3: Prehospital Triage, Primary Survey & Transfer Criteria

3.1 Initial Assessment, Primary Survey (ABCDEF), and Field Stabilization 3.2 Total Body Surface Area (TBSA) Calculation: Rule of Nines, Lund-Browder, and Palmar Method 3.3 American Burn Association (ABA) Burn Center Referral Criteria and Transport Logistics

4 Chapter 4: Fluid Resuscitation & Hemodynamic Stabilization (<72 Hours)

4.1 Fluid Resuscitation Formulas: Parkland (Baxter), Modified Brooke, and Consensus Protocols 4.2 Resuscitation Endpoints: Urine Output Titration, Base Deficit, and Hemodynamic Monitoring 4.3 Complications of Fluid Creep and Intra-Abdominal Hypertension / Abdominal Compartment Syndrome 4.4 Extremity Compartment Syndrome, Monitoring, and Emergent Escharotomy / Fasciotomy

5 Chapter 5: Airway Management & Inhalation Injury Management

5.1 Upper Airway Compromise, Indications for Early Endotracheal Intubation, and Airway Stabilization 5.2 Lower Airway Chemical Tracheobronchitis, Diagnostic Bronchoscopy, and Lung-Protective Mechanical Ventilation 5.3 Carbon Monoxide (CO) Toxicity, Cyanide Poisoning, and Specific Antidotes (Hydroxocobalamin)

6 Chapter 6: Acute Multisystem Assessment & Critical Care Management

6.1 Cardiovascular Derangements, Myocardial Depression, and Hemodynamic Optimization 6.2 Acute Kidney Injury, Rhabdomyolysis / Myoglobinuria, and Fluid-Electrolyte Shifts 6.3 Gastrointestinal Complications, Ileus, Early Enteral Nutrition, and Curling's Ulcer Prophylaxis 6.4 Neurological Impairment, Anemia of Burn Injury, Coagulopathy, and Musculoskeletal Protection

7 Chapter 7: Hypermetabolism & Nutritional Support

7.1 The Biphasic Metabolic Response: Ebb vs. Flow Phases and Persistent Hypermetabolism 7.2 Indirect Calorimetry, Caloric Equations (Curreri/Toronto), and Micronutrient / Trace Mineral Needs 7.3 Pharmacological Modulation: Propranolol, Oxandrolone, Growth Hormone, and Exercise Therapy 7.4 Stress Hyperglycemia, Intensive Insulin Protocols, and Adrenal / Thyroid Axis Dysregulation

8 Chapter 8: Pain Management in Burn Care

8.1 Pain Classification in Burns: Background, Procedural, Breakthrough, and Chronic Neuropathic Pain 8.2 Multimodal Analgesia: Opioids, Ketamine, Gabapentinoids, NSAIDs, and Regional Anesthesia 8.3 Non-Pharmacological Modalities: Virtual Reality, Cognitive Behavioral Techniques, Hypnosis, and Distraction

9 Chapter 9: Agitation, Delirium & Post-Burn Pruritus

9.1 Agitation Management, Targeted Sedation Protocols (RASS/SAS), and Circadian Rhythm Support 9.2 ICU Delirium: Risk Factors, Screening (CAM-ICU/ICDSC), Non-Pharmacological Bundles, and Medical Management 9.3 Post-Burn Itch: Histaminergic vs. Neuropathic Pruritus, Oral Antihistamines, Gabapentin, and Topical Emollients

10 Chapter 10: Burn Wound Assessment, Topical Antimicrobials & Dressings

10.1 Serial Wound Bed Assessment, Tissue Perfusion, and Documentation Standards 10.2 Topical Antimicrobial Formulations: Silver Sulfadiazine, Mafenide Acetate, Silver Nitrate, and Modern Silver Dressings 10.3 Wound Bed Preparation: Surgical, Enzymatic (Collagenase/Bromelain), Autolytic, and Mechanical Debridement 10.4 Modern Dressings, Hydrogels, Foam Dressings, Negative Pressure Wound Therapy (NPWT), and Moisture Retentive Balances

11 Chapter 11: Surgical Excision, Skin Grafting & Wound Closure

11.1 Principles of Early Tangential vs. Fascial Surgical Excision and Blood Conservation 11.2 Split-Thickness and Full-Thickness Autografting: Mesh Expansion Ratios vs. Sheet Grafts 11.3 Biologic Coverings, Dermal Regeneration Templates (Integra/Novosorb BTM), Allograft, and Xenograft 11.4 Autologous Cell Suspensions (ReCell), Cultured Epithelial Autografts (CEA), and Donor Site Management

12 Chapter 12: Burn Sepsis, Infection Control & Antimicrobial Therapy

12.1 Burn Center Infection Control: Contact Precautions, Hydrotherapy Sanitation, and Environmental Controls 12.2 Differentiating Hypermetabolic SIRS from Burn Sepsis: ABA Consensus Sepsis Criteria 12.3 Common Burn Pathogens (Pseudomonas, MRSA, Acinetobacter, Candida, Aspergillus) and Empiric Coverage 12.4 Invasive Burn Wound Infection: Clinical Signs, Quantitative Biopsy (>10^5 CFU/g), and Histopathological Invasion

13 Chapter 13: Specific Burn Etiologies: Electrical, Chemical & Cold Injuries

13.1 Electrical Burn Injuries: High-Voltage vs. Low-Voltage, Arc/Flash, Cardiac Monitoring, and Deep Muscle Necrosis 13.2 Chemical Injuries: Acids (Coagulation Necrosis), Alkalis (Liquefactive Necrosis), Hydrofluoric Acid (Calcium Gluconate), and Decontamination 13.3 Radiation Burns, Cutaneous Radiation Syndrome, Cold Injuries (Frostbite Triage and Thawing Protocols), and Vasodilator Therapy

14 Chapter 14: Special Burn Populations & Cutaneous Syndromes

14.1 Pediatric Burn Resuscitation (Maintenance Fluids + D5W), Surface Area Dynamics, and Non-Accidental Trauma Screening 14.2 Geriatric Burn Care: Thin Dermis, Altered Fluid Tolerance, Pre-existing Comorbidities, and Mortality Prognostication (Baux Score) 14.3 Burn Injury in Pregnancy: Maternal Physiology, Resuscitation, and Fetal Surveillance 14.4 Severe Cutaneous Adverse Reactions: Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), SCORTEN, and Specialized Burn Unit Nursing 14.5 Necrotizing Soft Tissue Infections and Friction/Shear Injuries

15 Chapter 15: Rehabilitation, Scar Management & Reconstruction

15.1 Anti-Deformity Positioning, Range-of-Motion Exercises, and Custom Splinting Across Major Joints 15.2 Hypertrophic Scarring Mechanisms, Myofibroblasts, and Vancouver Scar Scale (VSS) Assessment 15.3 Custom Pressure Garments (20-30 mmHg), Silicone Sheeting, Fractional CO2 Laser Resurfacing, and Contracture Release 15.4 Psychosocial Recovery, Post-Traumatic Stress Disorder (PTSD), Body Image Adaptation, Peer Support (Phoenix Society), and School/Work Reintegration 15.5 Discharge Teaching, Transition to Ambulatory Care, and Home Management

16 Chapter 16: Professional Practice, Ethics, Quality & Disaster Triage

16.1 Ethical Dilemmas in Burn Critical Care, Surrogate Decision-Making, Futility, and Palliative / End-of-Life Symptom Management 16.2 Interprofessional Burn Team Roles, Multidisciplinary Rounds, Structured Handoffs, and Patient/Family Advocacy 16.3 Burn Quality Improvement, American Burn Association (ABA) Verification Standards, and National Burn Repository (NBR) Benchmarking 16.4 Diversity, Equity, Inclusion, and Intraprofessional Nursing Development 16.5 Community Outreach, Burn Prevention Education, and Home Safety 16.6 Mass Casualty Burn Disasters, Secondary Triage Schemes (ABA/ABLS Triage Matrix), Surge Capacity, and CBRN/HAZMAT Emergency Response

11.2 Split-Thickness and Full-Thickness Autografting: Mesh Expansion Ratios vs. Sheet Grafts

Key Takeaways Explain This Topic AI

Autografts provide the definitive, permanent gold standard for burn wound closure; split-thickness skin grafts (STSG) harvest the epidermis and a variable portion of the dermis, whereas full-thickness skin grafts (FTSG) contain the epidermis and the entire dermis.

STSGs are classified as thin (0.008–0.012 in), medium (0.012–0.018 in), or thick (0.018–0.022 in); thinner STSGs take more rapidly with lower metabolic demands, but thicker STSGs provide superior durability, cosmetic texture, and reduced secondary wound contracture.

Sheet grafts represent the absolute gold standard for aesthetically and functionally critical aesthetic units (face, anterior neck, hands); they require vigilant nursing evacuation of underlying seromas/hematomas via rolling or sterile pie-crusting to maintain graft-bed adherence.

Meshed autografts (expansion ratios 1:1.5 to 1:6) maximize donor coverage and allow drainage through lattice interstices, but leave permanent 'waffle-pattern' scarring and require prolonged periods for epithelial bridging across open wound spaces.

Graft integration proceeds through three distinct chronological phases: Plasmatic Imbibition (0–48 hours; passive nutrient diffusion), Inosculation (48–72 hours; direct capillary alignment and anastomosis), and Revascularization/Maturation (>72 hours; lymphatic recanalization and collagen anchoring). Graft loss is predominantly caused by sub-graft hematoma/seroma, mechanical shear, infection, or avascular beds.

Last updated: August 2026

11.2 Split-Thickness and Full-Thickness Autografting: Mesh Expansion Ratios vs. Sheet Grafts

Core Knowledge: The definitive goal of acute surgical burn management is permanent wound coverage with healthy autologous tissue. An autograft (tissue transplanted from one anatomical site to another on the same individual) remains the only permanent biological skin replacement. Certified Burn Registered Nurses (CBRNs) must possess comprehensive expertise in graft classification, meshing mechanics, the biological timeline of graft "take" (inosculation), and specialized post-operative nursing interventions to prevent graft loss.

1. Skin Graft Classification: Split-Thickness vs. Full-Thickness Autografts

Skin grafts are categorized based upon the anatomical depth of the harvested cutaneous layers. The biological behavior, cosmetic result, and donor site recovery differ substantially between split-thickness and full-thickness grafts. SKIN GRAFT HARVEST DEPTH ANATOMY

  • [ Epidermis ] ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
  • ── ── ── ── ── ── ── ── ── ── ── ── ── ── ── ◄── Thin STSG (0.008–0.012")
  • [ Papillary ] ▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒
  • [ Dermis ] ── ── ── ── ── ── ── ── ── ── ── ── ── ── ── ◄── Medium STSG (0.012–0.018")
  • [ Reticular ] ▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒
  • [ Dermis ] ── ── ── ── ── ── ── ── ── ── ── ── ── ── ── ◄── Thick STSG (0.018–0.022")
  • ═══════════════ ════════════════════════════════════════════ ◄── FTSG (Epidermis + Full Dermis)
  • [ Subcut. Fat ] ▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓▓
  • Split-Thickness Skin Grafts (STSG)

A Split-Thickness Skin Graft (STSG) contains the entire epidermis and a variable portion of the underlying dermis. STSGs are harvested using calibrated power dermatomes (e.g., Zimmer or Padgett) and are categorized by harvest depth:

Thin STSG (0.008 to 0.012 inches / 0.2 to 0.3 mm): Contains minimal dermis. Displays the fastest rate of plasmatic imbibition and revascularization, lowest metabolic requirements, and highest rate of graft "take" even on suboptimal wound beds. Donor sites re-epithelialize rapidly (within 7 to 10 days). However, thin STSGs possess poor mechanical durability, transmit underlying wound bed contraction, and carry a high risk of severe secondary contracture .

Medium STSG (0.012 to 0.018 inches / 0.3 to 0.45 mm): The most common workhorse graft for general burn coverage. Strikes an optimal balance between reliable revascularization, donor healing time (10 to 14 days), and structural durability.

Thick STSG (0.018 to 0.022 inches / 0.45 to 0.55 mm): Retains a substantial dermal layer containing structural collagen, elastin, and adnexal remnants. Provides superior skin texture, excellent durability, and significantly less secondary contracture. However, it requires a pristine, highly vascular recipient bed, has a slower rate of vascular take, and leaves a deeper donor site that heals slowly (14 to 21+ days) with a higher risk of hypertrophic scarring.

Full-Thickness Skin Grafts (FTSG)

A Full-Thickness Skin Graft (FTSG) includes the epidermis and the entire dermis down to, but excluding, the subcutaneous fat. (Any adherent hypodermal fat must be meticulously defatted with tenotomy scissors prior to grafting, as fat is avascular and blocks diffusion).

Primary vs. Secondary Contracture Dynamics:

Primary Contracture: The immediate elastic recoil that occurs immediately upon harvesting the graft from the donor bed. FTSGs exhibit the highest primary contracture (shrinking by up to 40% immediately upon excision) because they contain abundant elastin fibers in the deep reticular dermis.

Secondary Contracture: The progressive tightening and shrinking of the grafted wound bed over weeks to months driven by wound bed myofibroblasts. FTSGs demonstrate minimal to no secondary contracture because the thick, intact dermal collagen inhibits recipient bed myofibroblast activity.

Clinical Indications: Reserved for high-value aesthetic and functional units requiring maximum contour matching, normal skin texture, pigmentation, and resistance to contraction: eyelids, perioral area, nasal dorsum, face, anterior neck, palmar hands, and joint flexion creases .

Donor Site Management: Because no dermal remnants remain in the donor wound bed, FTSG donor sites cannot re-epithelialize spontaneously . The donor defect must be closed surgically via primary linear closure (e.g., groin crease, supraclavicular fossa, retroauricular crease) or covered with an STSG.

Comparative Analysis: STSG vs. FTSG

  • Feature Split-Thickness Skin Graft (STSG) Full-Thickness Skin Graft (FTSG)
  • Tissue Composition Epidermis + variable portion of dermis Epidermis + entire dermis (defatted)
  • Harvest Thickness 0.008 to 0.022 inches (0.2–0.55 mm) Full dermal depth (variable by site)
  • Primary Contracture Low (minimal immediate elastic recoil) High (recoils 30–40% immediately upon harvest)
  • Secondary Contracture High (especially thin STSGs) Minimal / None (inhibits wound bed myofibroblasts)
  • Vascular Demands Low to moderate; rapid plasmatic take High ; requires pristine vascular recipient bed
  • Cosmetic & Texture Variable; often shiny, hypopigmented Superior ; natural color, texture, and contour

Durability / Sensation Moderate; sensation returns incompletely High ; superior sensation and sweat gland recovery

Donor Site Healing Spontaneous re-epithelialization (7–14 days) Must be closed primarily or grafted with STSG

Primary Clinical Use Extensive burn coverage, trunk, extremities Eyelids, face, neck, palmar surfaces, joint creases

2. Sheet Grafts vs. Meshed Autografts

The decision to apply an autograft as a solid, continuous sheet or pass it through a mechanical mesher is dictated by the anatomical location, cosmetic requirements, and total percentage of available donor skin. MESH EXPANSION RATIOS & SCARRING

  • [ Sheet Graft ] ████████████████████ (No slits; pristine cosmetic outcome)
  • [ Mesh 1:1.5 ] █ █ █ █ █ █ █ █ █ █ (Small diamond slits; 5–7 day closure)
  • [ Mesh 1:2.0 ] █ █ █ █ █ █ █ (Moderate slits; 7–10 day closure)
  • [ Mesh 1:3.0 ] █ █ █ █ █ (Large diamond open spaces; 10–14 days)
  • [ Mesh 1:6.0 ] █ █ █ █ (Massive open gaps; requires allograft overlay)
  • Sheet Autografts (Unmeshed Grafts)

A sheet graft is a continuous, uninterrupted piece of harvested split-thickness or full-thickness skin applied directly to the wound bed without mechanical perforation.

Indications: Mandated for the face, anterior neck, dorsal and palmar hands, feet, and across major joint axes .

Advantages: Delivers the gold standard in cosmetic appearance, provides a smooth, uniform surface without lattice scarring, and exhibits maximal resistance to secondary contracture.

The Seroma/Hematoma Vulnerability: Because sheet grafts have no pre-existing drainage holes, any blood, serum, or liquefied fat accumulating beneath the graft will separate the graft from the underlying capillary bed, causing local ischemia and necrosis.

Nursing Protocols for Sheet Grafts:

Post-Operative Evacuation: Inspect sheet grafts frequently in the immediate post-operative period. Small seromas or hematomas must be evacuated by gently rolling a sterile cotton-tipped applicator (swab) from the center of the graft toward the periphery or through small marginal slits.

Sterile Fenestration ("Pie-Crusting"): If a discrete, non-draining fluid pocket is identified under the sheet graft, the nurse or surgeon performs a precise sterile puncture or micro-slit (pie-crusting) using a #11 scalpel blade or 18-gauge needle directly over the collection, followed by gentle expression of the fluid and re-application of compressive dressings.

Meshed Autografts and Expansion Ratios

A meshed graft is created by feeding an STSG through a mechanical skin mesher containing staggered cutting rollers. The machine cuts an array of offset slits, transforming the solid skin sheet into an expandable diamond lattice.

Expansion Ratios:

1:1.5 Expansion: Standard ratio for moderate to large burns. Provides modest surface area expansion while maintaining close proximity between epithelial bridges. Interstices close rapidly within 5 to 7 days with acceptable cosmetic results.

1:2 to 1:3 Expansion: Utilized when donor sites are limited ( 30 % to 50 % TBSA burns 30\%\text{ to }50\%\text{ TBSA burns} 30% to 50% TBSA burns ). Expands surface area significantly. Interstitial closure requires 10 to 14 days .

1:4 to 1:6 Expansion: Reserved for massive burns ( > 60 % TBSA >60\%\text{ TBSA} > 60% TBSA ) with severe donor site exhaustion. Creates wide open diamond spaces. Epithelialization of the vast raw interstitial gaps takes 14 to 21+ days , during which the wound is susceptible to desiccation and infection. Widely meshed grafts ( > 1 : 3 >1:3 > 1 : 3 ) are typically covered with an allograft overlay (the "sandwich technique" or Alexander technique) to protect the open interstices while keratinocytes migrate.

Advantages: Greatly expands available donor skin surface area; allows fluid, blood, and inflammatory exudate to drain freely through the mesh interstices (greatly reducing hematoma-induced graft loss); conforms easily to irregular anatomical contours.

Disadvantages: Produces a permanent, lifelong "pebble" or "waffle-like" lattice scar ; interstitial gaps close by secondary intention, resulting in increased myofibroblast activity and severe wound contracture ; fragile healing until complete interstitial epithelial bridging is achieved.

3. Biological Phases of Skin Graft "Take" (Inosculation Timeline)

Skin graft survival on an excised recipient bed requires an intricate sequence of biological events known as graft "take." This process occurs across three chronologically distinct, overlapping phases: TIMELINE OF SKIN GRAFT "TAKE"

  • 0 Hours 24 Hours 48 Hours 72 Hours 7+ Days
  • ├──────────────────┼──────────────────┼──────────────────┼──────────────────┤
  • │◄── PLASMATIC IMBIBITION ───────────►│ │
  • │ (Passive serum absorption, │ │
  • │ 30-40% weight gain, fibrin glue) │ │
  • │ │◄── INOSCULATION ───────────────────►│
  • │ │ (Capillary budding, anastomosis, │
  • │ │ "kissing vessels", pink flush) │
  • │ │ │ │
  • │ │ │◄── MATURATION ──►│
  • │ │ │ (Lymphatics, │
  • │ │ │ collagen ties)│
  • Phase 1: Plasmatic Imbibition (First 24 to 48 Hours)

During the initial 24 to 48 hours following transplantation, the skin graft is completely avascular. It survives solely through the passive absorption of wound bed exudate:

Mechanism: Fibrinogen in the recipient wound bed polymerizes into a delicate fibrin network , which acts as a biological adhesive anchoring the graft. The graft passively absorbs plasma, glucose, electrolytes, and oxygen from the recipient bed by capillary action.

Clinical Manifestations: The graft appears pale, cool, and edematous, increasing in total weight by 30% to 40% over the first 24 hours. The graft is exquisitely vulnerable to mechanical shear stresses , which instantly tear the microscopic fibrin strands and cause graft necrosis.

Phase 2: Inosculation and Early Revascularization (48 to 72 Hours)

Between post-operative hours 48 and 72, true vascular connections are established between the host wound bed and the transplanted donor tissue:

Mechanism: Two concurrent vascular processes occur:

Direct Inosculation ("Kissing Vessels"): Pre-existing capillary loops in the recipient wound bed make direct end-to-end alignment and functional anastomoses with pre-existing endothelial channels in the donor graft dermis.

Neovascularization (Angiogenesis): Host endothelial capillary buds sprout and invade the donor graft dermis, establishing new vascular channels.

Clinical Manifestations: The graft transitions from a pale, ischemic appearance to a warm, pink, hyperemic color . Gentle pressure demonstrates blanching with brisk capillary refill, confirming functional perfusion.

Phase 3: Revascularization, Lymphatic Ingrowth, and Maturation (>72 Hours to Weeks)

From day 4 onward, the vascular architecture matures and definitive tissue integration occurs:

Lymphatic Recanalization: Functional lymphatic vessels invade the graft by post-operative day 5 to 7 , allowing accumulated interstitial fluid to drain and resolving the edema of plasmatic imbibition.

Fibroblast Proliferation & Anchoring: Fibroblasts migrate across the interface, depositing organized Type I and Type III collagen bundles that permanently anchor the graft to the recipient bed.

Neurotization (Sensory Reinnervation): Regenerating peripheral nerve axons sprout into the graft over months. Sensation returns in a predictable sequence: deep touch and pressure sensations return first, followed by pain perception, and lastly temperature sensation. Fine discriminatory touch and sweating (sudomotor function) are often permanently impaired in thin STSGs.

4. Etiologies of Graft Failure and CBRN Nursing Prevention Protocols

Skin graft failure compromises clinical outcomes, exhausts donor sites, and prolongs hospitalization. The Certified Burn Registered Nurse must recognize the four primary mechanisms of graft failure and execute rigorous preventive interventions: MECHANISMS OF GRAFT FAILURE

  • ┌────────────────────────────────────────────────────────────────────────┐
  • │ [1] HEMATOMA / SEROMA ACCUMULATION │
  • │ • #1 Most Common Cause of Early Graft Loss │
  • │ • Fluid layer >0.5 mm creates physical barrier to nutrient diffusion │
  • │ • Prevents plasmatic imbibition and blocks capillary inosculation │
  • ├────────────────────────────────────────────────────────────────────────┤
  • │ [2] MECHANICAL SHEARING & MOTION │
  • │ • Dislodges graft from recipient bed during repositioning / transfers │
  • │ • Tears microscopic fibrin bonds and budding capillary anastomoses │
  • ├────────────────────────────────────────────────────────────────────────┤
  • │ [3] INFECTION & BACTERIAL PROTEOLYSIS │
  • │ • Streptococcus pyogenes (Group A Strep) produces streptokinase │
  • │ • Pseudomonas aeruginosa releases elastases; rapidly dissolves graft │
  • ├────────────────────────────────────────────────────────────────────────┤
  • │ [4] INADEQUATE EXCISION / AVASCULAR BED │
  • │ • Grafts placed over residual necrotic dermis, avascular fat, or bone │
  • │ • Insufficient capillary density to support plasmatic imbibition │
  • └────────────────────────────────────────────────────────────────────────┘
  • Nursing Protocols for Graft Protection

Immobilization and Splinting: Apply rigid or semi-rigid orthotic splints to maintain joints in anti-deformity functional positions (e.g., neck extension, elbow extension, wrist extension at 30°, MCP flexion at 70–90°, IP extension, ankle neutral at 90°). Maintain strict bed rest and joint immobilization for 3 to 5 days post-grafting.

Negative Pressure Wound Therapy (NPWT / VAC): Apply continuous NPWT at − 75 to − 125 mmHg -75\text{ to }-125\text{ mmHg} − 75 to − 125 mmHg over newly grafted beds. NPWT provides uniform continuous bolster pressure, eliminates dead space, continuously evacuates sub-graft hematomas and seromas, inhibits bacterial colonization, and halts mechanical shear during nursing care.

Meticulous Dressing Management: Outer bolster dressings (cotton bolsters, tie-over sutures, negative pressure dressings) are typically left undisturbed for 3 to 5 days unless strike-through drainage, foul odor, or fever indicates graft compromise. When changing inner non-adherent contact layers (e.g., petrolatum gauze, silicone mesh), soak thoroughly with sterile saline to prevent tearing the fragile budding capillaries.

Infection Surveillance: Monitor for graft-threatening pathogens. Group A Beta-Hemolytic Streptococcus ( Streptococcus pyogenes ) is a surgical emergency; its extracellular streptokinase and hyaluronidase enzymes rapidly dissolve the fibrin anchor, destroying an entire graft within 12 to 24 hours. Notify the surgical team immediately if rapid graft dissolution, fiery spreading erythema, or high fever occurs.